Shade Tree Advisors’s Clinuvel Pharmaceuticals CUVL Stock Holding History

Shade Tree Advisors’s Portfolio CUVL Stock Details CUVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$122K	Buy	+20,453	New	+$133K	0.07%	63

Shade Tree Advisors's CUVL Position: Q3 2026 in Review

Shade Tree Advisors opened a new position in Clinuvel Pharmaceuticals (CUVL) in Q3 2026: 20,453 shares worth $122K. The stake represents 0.07% of the portfolio and ranks #63 among its holdings.

1 fund tracked by Wall St. Rank holds CUVL as of Q3 2026.

Shade Tree Advisors held 20,453 shares of Clinuvel Pharmaceuticals worth $122K as of Q3 2026.
Clinuvel Pharmaceuticals was a new Shade Tree Advisors position in Q3 2026.
Clinuvel Pharmaceuticals made up 0.07% of Shade Tree Advisors's portfolio in Q3 2026, its #63 holding.
1 fund tracked by Wall St. Rank held Clinuvel Pharmaceuticals as of Q3 2026.

Based on Shade Tree Advisors's 13F filing for Q3 2026, filed 22 Oct 2026.